Hudson River Biotechnology is an innovation-oriented company, with many brilliant scientists in the team. So how do we create an

March 15, Wageningen – To combat the current issues prevalent in field crop care, HRB and SE collaborated on PlentranceTM:

Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University, joins

Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel

Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for

Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the

In an opinion piece on AgFunder, our founders Rudi Ariaans and Ferdinand Los argue that CRISPR is the best tool the EU has to achieve

Bionieuws, the Dutch magazine for biologists interviewed our CSO Ferdinand Los, and published a short company profile in their magazine. Read

Prof. John van der Oost, head of the Bacterial Genetics group in the Laboratory of Microbiology at Wageningen University, has